Document is current
Any future updates will be listed below
-
Authors
Skrobanski, Hanna
Vyas, Kishan
Bowditch, Sally https://orcid.org/0000-0002-6918-2936
Hubig, Lena
Dziadulewicz, Edward
Fish, Louise
Takhar, Pooja
Lo, Siu Hing
-
Funding
Funding for this research was provided by:
GW Pharmaceuticals, Cambridge, UK, now part of Jazz Pharmaceuticals, Inc. (GW Pharmaceuticals, Cambridge, UK, now part of Jazz Pharmaceuticals, Inc.)
- License Information
-
More Information
Article History
Received: 24 January 2023
Accepted: 11 March 2023
First Online: 11 April 2023
Declarations
:
: The protocol, participant information sheet and informed consent form, and survey were approved by WCG Institutional Review Board (tracking number: 20211736).
: Not applicable.
: Neither honoraria nor payments were made for authorship. S. Bowditch, E. Dziadulewicz, and K. Vyas are employees of Jazz Pharmaceuticals, Inc. S. Bowditch and E. Dziadulewicz hold stock/stock options in Jazz Pharmaceuticals, Inc. H. Skrobanski, L. Hubig, and S.H. Lo are employees of Acaster Lloyd Consulting Ltd which received payment by GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc., in the conduct of this study. L. Fish is an employee of Genetic Alliance UK and was an employee of TSA when the study was conducted, and P. Takhar is an employee of TSA; TSA has received sponsorship for events, an unrestricted educational grant, and consulting fees from GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc.
